04:51pm Tuesday 21 January 2020

UNMC, Creighton research challenges current views for genetic causes of familial breast cancer

A finding published recently by researchers at the University of Nebraska Medical Center and Creighton University, challenges current approaches in identifying breast cancer in families with a genetic link. The paper also might explain why despite progress in the past two decades, identifying genetic connections for the majority of breast cancer that runs in families has been slow.

The study is published in the September/October issue of The Breast Journal.

Currently there are an estimated 30 to 50 gene mutations identified that affect about 30 to 40 percent of women with familial breast cancer — with BRCA 1 and 2 being the most common.

“So many people get breast cancer but we cannot find the cause for most of it,” said San Ming Wang, M.D., senior author of the article and associate professor in the UNMC Department of Genetics, Cell Biology and Anatomy. “Our study showed that many families have their own genetic factors that contribute to the disease. This finding goes against the existing theory, which has been that the same disease must have the same cause.

“But our data shows that the same disease can have different causes. People have been focused on finding a common mutation among different families. As many families have their own genetic causes, searching for a common cause will not work. This can explain why after almost 20 years we haven’t made significant progress.”

In the study, the research team sequenced all 20,000 or so genes in each of the eight members of a family, with five women affected by breast cancer in three generations. They discovered the family has the mutated gene KAT6B. The gene is known to be associated with many types of cancer but not before associated with breast cancer, Dr. Wang said.

He said they tested the same gene mutation in 40 other families with familial breast cancer but didn’t see mutations in those families. Since publishing the study, the team analyzed 30 more families with familial breast cancer consistent with the study results.

“Our data shows it’s very likely that many families have different mutations, which directly supports our concept of same disease, different causes,” Dr. Wang said.

Dr. Wang said advances in DNA technology and the DNA bank of Henry Lynch, M.D., of Creighton University, lent success to the project. Dr. Lynch has one of the nation’s best collections of DNA from familial cancer patients, which is used by researchers all over the world.

“Our registry’s unique focus on family – relationships, connected cancer diagnoses and biological samples – lends itself to discoveries such as this,” said Dr. Lynch, professor and chair of the Creighton University Department of Preventative Medicine and Public Health and director of the Hereditary Cancer Center at Creighton University Medical Center. “This is nowhere near the end of our collaboration in this field. We hope to apply this concept and method to other families in our registry, as well as other types of cancer.”

The database also aided in Dr. Lynch’s discovery of the Hereditary Breast Ovarian Cancer syndrome, the Lynch syndrome and others.

The study grant was funded by the UNMC Eppley Institute for Research in Cancer and Allied Diseases, the Charles F. and Mary C. Heider Chair in Cancer Research and the Nebraska Tobacco Settlement Biomedical Research Fund awarded to Creighton University.

The research team included UNMC researchers Ken Cowan, M.D., Ph.D., Yeong Kim, Ph.D., Pei Xian Chen, M.D., Fengxia Xiao, M.D., and Bradley Downs; Creighton University researchers, Carrie Snyder and Yulia Kinarsky, and University of Utah researcher, David Goldgar, Ph.D.

Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Its education programs train more health professionals than any other institution in the state. Learn more at unmc.edu.

Creighton University, a Catholic, Jesuit institution located in Omaha, Neb., enrolls more than 4,200 undergraduate and 3,500 professional school and graduate students. No other university its size offers students such a comprehensive academic environment coupled with personal attention from faculty-mentors. With nine colleges and schools on the same campus, Creighton affords incomparable interdisciplinary learning and unique opportunities for collaborative research among arts and sciences, business, health sciences and law. Creighton has been a top-ranked Midwestern regional university in the college edition of U.S. News & World Report magazine for more than 20 years. For more information, visit our website at: www.creighton.edu.



Share on:

MORE FROM Breast Cancer

Health news